企業プロフィール
Q32 Bio Inc 株価・ニュース・カタリスト
- ティッカー:
- QTTB
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
16.36 USD (+2.44%)
終値
最終更新: 2026年8月24日
214M USD
時価総額
株価変動の要因
As of Aug 24, 2026, QTTB closed up 2.44% at $16.36. No new same-company headline was identified in the current news window.
企業概要
事業概要
Q32 Bio is a biotechnology company focused on inflammation and immune modulation through complement or related pathways. Its story is built around targeting hard immune-mediated diseases with a specific biological mechanism.
所在地とセクター分類
Q32 Bio is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology biotechnology.
ビジネスモデルの特徴
The company depends on clinical validation, translational progress, and the ability to keep a narrow pipeline funded. Investors usually watch early data and strategic changes.
バイオ業界での位置付け
Q32 occupies a niche immunology position within biotech. It is catalyst-sensitive because the market needs proof that the pathway can create real clinical differentiation.
今後のカタリスト
- Q32 Bio's catalysts are bempikibart's alopecia-areata Phase 2 readout, the ongoing SIGNAL-AA / SIGNAL-AD program cadence, and any strategic decision around the complement platform. The company still needs each clinical step to show that the IL-7Rα story is moving from a promising signal into a durable immune-disease franchise.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。